Unicycive Therapeutics Inc (UNCY) — Financial Flexibility Index
Unicycive Therapeutics Inc (UNCY) has a Financial Flexibility Index of -0.42x as of December 2025. Free cash flow of $-8.03 Million (operating CF $-8.03 Million minus capex $0.00) represents 0% of total liabilities ($18.94 Million). Check how strategically is Unicycive Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Unicycive Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Unicycive Therapeutics Inc across 8 annual periods. See working capital to net assets of Unicycive Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Unicycive Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Unicycive Therapeutics Inc. For the full company profile including market capitalisation, see market value of Unicycive Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.65x | $-31.29 Million | $-31.32 Million | $18.94 Million | ▼ -40.5% |
| 2024 | -1.18x | $-28.50 Million | $-28.57 Million | $24.24 Million | ▼ -15.9% |
| 2023 | -1.02x | $-18.27 Million | $-18.28 Million | $18.00 Million | ▲ +78.7% |
| 2022 | -4.77x | $-15.65 Million | $-15.65 Million | $3.28 Million | ▼ -87.7% |
| 2021 | -2.54x | $-5.74 Million | $-5.77 Million | $2.26 Million | ▼ -410.5% |
| 2020 | -0.50x | $-1.43 Million | $-1.46 Million | $2.88 Million | ▲ +60.8% |
| 2019 | -1.27x | $-1.15 Million | $-1.18 Million | $903.00K | ▼ -110.3% |
| 2018 | -0.60x | $-746.00K | $-775.00K | $1.24 Million | — |